Baxa Corporation

Baxa Corporation announces the addition of four specialty administration sets to the MicroFuse Syringe Infusion System line. These new sets incorporate a T-site for the convenient administration of coronary vasodilators during myocardial perfusion imaging. The new MicroFuse Administration Sets feature an integrated, T-site injection port close to the set outlet. This easy-access port facilitates the addition of a secondary medication during cardiac monitoring procedures, minimizing the opportunity for medication error or the introduction of touch contamination.

www.baxa.com